Graft loss · kidney transplant recipients
ACE Inhibitors showed no clear difference in graft loss compared with calcium channel blockers (low certainty).
1 finding from 1 review
GFR · kidney transplant recipients
1 finding from 1 review
Acute rejection · kidney transplant recipients
It is very uncertain whether ACE Inhibitors changes acute rejection compared with calcium channel blockers (very low certainty).
1 finding from 1 review
Proteinuria · kidney transplant recipients
1 finding from 1 review
Graft loss · kidney transplant recipients
Calcium channel blockers may leads to lower graft loss compared with placebo/no treatment (low certainty).
1 finding from 1 review
Haemoglobin (g/dL) · kidney transplant recipients
1 finding from 1 review
Blood loss: post‐treatment haematocrit (%) · kidney transplant recipients
1 finding from 1 review
GFR · kidney transplant recipients
1 finding from 1 review
Acute rejection · kidney transplant recipients
Calcium channel blockers showed no clear difference in acute rejection compared with placebo/no treatment (low certainty).
1 finding from 1 review
Discontinuation of treatment due to side effects ( · kidney transplant recipients
Calcium channel blockers showed no clear difference in withdrawal due to side effects compared with placebo/no treatment (low certainty).
1 finding from 1 review
Proteinuria · kidney transplant recipients
1 finding from 1 review
Blood pressure · kidney transplant recipients
1 finding from 1 review
Death · kidney transplant recipients
ACE inhibitors showed no clear difference in death compared with placebo/no treatment (low certainty).
1 finding from 1 review
Graft loss · kidney transplant recipients
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 2 days ‐ immediate treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days‐ short‐term treatment · patients with acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 10 days‐ short‐term treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 2 days ‐ immediate treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days ‐ short‐term treatment · acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 10 days ‐ short‐term treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 2 days ‐ immediate treatment (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days ‐ short‐term treatment · patients with acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 10 days ‐ short‐term treatment (high certainty).
1 finding from 1 review